Remove 2025 Remove Diabetes Remove Individual Remove Patients
article thumbnail

Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets.

Physician's Weekly

The number of patients with heart failure is expected to rise sharply owing to ageing populations, poor dietary habits, unhealthy lifestyles and improved survival rates from conditions such as hypertension and myocardial infarction. Springer Nature Limited. first appeared on Physician's Weekly.

article thumbnail

Health and Mood Benefits of Semaglutide in HF

Physician's Weekly

Semaglutide therapy in patients with obese heart failure leads to marked weight loss and notable gains in mood, function, and QoL over the course of 1 year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Redesigning Primary Care Workflows to Optimize Obesity Management

Physician's Weekly

The PATHWEIGH trial aims to embed structured obesity care into primary care, addressing barriers and boosting clinician confidence and patient outcomes. Through this model, PATHWEIGH seeks to improve both the clinical delivery of weight management services and patient outcomes.

article thumbnail

How to manage GLP-1s in the hospital

Today's Hospitalist

Medical societies and hospitals are weighing in on periprocedural concerns in patients taking GLP-1s who need procedures or surgeries. That’s according to two internists who work closely with hospitalized patients who take GLP-1s. These medications are truly life-changing for many patients.”

article thumbnail

Guideline Influence on PFO Identification and Stroke Prognosis

Physician's Weekly

The results showed that 13,780 individuals experienced ischemic stroke, with a crude annual incidence of 30.3 The PFO was identified in 749 patients (5.4%), who were generally younger and had fewer risk factors compared to non-PFO patients (all P value < 0.05). per 1,00,000 inhabitants/year. per 1,00,000 inhabitants/year.

article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

Share Tweet Share Email Home Psychology & Psychiatry Home Addiction June 16, 2025 The GIST Texas invests $50M in psychedelic drug research to treat addiction by I. Journal information: Nature Medicine © 2025 HealthDay. More information: ScienceDirect has more on ibogaine. All rights reserved.

article thumbnail

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

Medical Xpress

In a study published in Nature Communications , led by researchers at National Taiwan University (NTU) and National Tsing Hua University (NTHU), scientists used the deepest-ever two-photon calcium imaging in awake mice to directly observe how individual SCN neurons respond to light.

Provider 109